136 related articles for article (PubMed ID: 22957989)
1. Cutaneous graft versus host disease in pediatric multivisceral transplantation.
Feito-Rodríguez M; de Lucas-Laguna R; Gómez-Fernández C; Sendagorta-Cudós E; Collantes E; Beato MJ; Boluda ER
Pediatr Dermatol; 2013; 30(3):335-41. PubMed ID: 22957989
[TBL] [Abstract][Full Text] [Related]
2. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
3. The current status of multivisceral transplantation.
Mao Q; Li YS; Li JS
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):345-50. PubMed ID: 19666401
[TBL] [Abstract][Full Text] [Related]
4. Safe inclusion of the entire pancreas as a component of the multivisceral graft.
Vianna R; Fridell JA; Mangus R; Hollinger EF; Matiosky A; Tector AJ
Transplantation; 2008 Jul; 86(1):114-6. PubMed ID: 18622287
[TBL] [Abstract][Full Text] [Related]
5. Post-intestine transplant graft-vs-host disease associated with inclusion of a liver graft and with a high mortality risk.
Clouse JW; Kubal CA; Fridell JA; Pearsall EJ; Mangus RS
Clin Transplant; 2019 Jan; 33(1):e13409. PubMed ID: 30222903
[TBL] [Abstract][Full Text] [Related]
6. Atopic dermatitis-like presentation of graft-versus-host disease: a novel form of chronic cutaneous graft-versus-host disease.
Wei J; Zhang Y; Xu H; Jin J; Zhang J
J Am Acad Dermatol; 2013 Jul; 69(1):34-9. PubMed ID: 23375455
[TBL] [Abstract][Full Text] [Related]
7. [Transplantation en masse of abdominal organs].
Starzl T
Ann Gastroenterol Hepatol (Paris); 1992; 28(1):39-43. PubMed ID: 1554235
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Yanik G; Levine JE; Ratanatharathorn V; Dunn R; Ferrara J; Hutchinson RJ
Bone Marrow Transplant; 2000 Jul; 26(2):161-7. PubMed ID: 10918426
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment for graft-versus-host disease after pancreas transplantation.
Chang Jw; Sageshima J; Ciancio G; Mattiazzi A; Chen L; Tsai HL; Ruiz P; Burke GW
Clin Transplant; 2014 Feb; 28(2):217-22. PubMed ID: 24433450
[TBL] [Abstract][Full Text] [Related]
10. Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD.
Zuber J; Rosen S; Shonts B; Sprangers B; Savage TM; Richman S; Yang S; Lau SP; DeWolf S; Farber D; Vlad G; Zorn E; Wong W; Emond J; Levin B; Martinez M; Kato T; Sykes M
Am J Transplant; 2015 Oct; 15(10):2691-703. PubMed ID: 25988811
[TBL] [Abstract][Full Text] [Related]
11. Graft-vs-host disease after small bowel transplantation in children.
Andres AM; Santamaría ML; Ramos E; Sarriá J; Molina M; Hernandez F; Encinas JL; Larrauri J; Prieto G; Tovar JA
J Pediatr Surg; 2010 Feb; 45(2):330-6; discussion 336. PubMed ID: 20152346
[TBL] [Abstract][Full Text] [Related]
12. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease.
Calzavara Pinton P; Porta F; Izzi T; Venturini M; Capezzera R; Zane C; Notarangelo LD
Haematologica; 2003 Oct; 88(10):1169-75. PubMed ID: 14555314
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-host disease after intestinal and multivisceral transplantation.
Wu G; Selvaggi G; Nishida S; Moon J; Island E; Ruiz P; Tzakis AG
Transplantation; 2011 Jan; 91(2):219-24. PubMed ID: 21076376
[TBL] [Abstract][Full Text] [Related]
14. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
[TBL] [Abstract][Full Text] [Related]
15. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
16. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
Elad S; Or R; Resnick I; Shapira MY
Transpl Int; 2003 Sep; 16(9):665-70. PubMed ID: 12768230
[TBL] [Abstract][Full Text] [Related]
17. [Skin manifestations of graft-versus-host reaction following bone marrow transplantation].
Itin PH; Lautenschlager S; Orth B; Rufli T; Gratwohl A
Schweiz Med Wochenschr; 1996 Mar; 126(9):339-47. PubMed ID: 8701251
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of chronic cutaneous graft-versus-host disease in Japanese leukemia patients after bone marrow transplantation: low incidence and mild manifestations of skin lesions.
Fujii H; Hiketa T; Matsumoto Y; Ohashi M; Miyamura Y; Tanimoto M; Morishima Y; Saito H; Horibe K; Shibata Y
Bone Marrow Transplant; 1992 Oct; 10(4):331-5. PubMed ID: 1422488
[TBL] [Abstract][Full Text] [Related]
19. PUVA therapy for chronic cutaneous graft-vs-host disease.
Jampel RM; Farmer ER; Vogelsang GB; Wingard J; Santos GW; Morison WL
Arch Dermatol; 1991 Nov; 127(11):1673-8. PubMed ID: 1952971
[TBL] [Abstract][Full Text] [Related]
20. Life-threatening graft-vs-host disease.
Vargas-Díez E; García-Díez A; Marín A; Fernández-Herrera J
Clin Dermatol; 2005; 23(3):285-300. PubMed ID: 15896544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
